Trends of Macrosomia at University Clinics of Kinshasa

Andy, Mbangama-Muela; Sylvain, Mulumba Kapuku; Rachid, Tozin Rahma; Joëlle, Lumaya Ambis; Barthélémy, Tandu-Umba; Roger, Mbungu Mwimba; Vicky, Lokomba Bolamba; Damien, Mbanzulu Pita

doi:10.4236/ojog.2018.83028

Cited by 3 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to studies, the risk of delivering a macrosomic infant is increased in multiparous women [14]. Our result is similar to those reported in Senegal in 2017 [15], Congo [16] and Mali in 2018 [17].…”

Section: Maternal Medical and Gynaeco-obstetric Datasupporting

confidence: 90%

Fetal Macrosomia And Associated Factors at The National Hospital Center of Pikine (CHNP) Dakar/ Senegal

Ly¹,

Fall²,

Kane³

et al. 2022

Pediatr Neonatol Med

View full text Add to dashboard Cite

Introduction: Fetal macrosomia is a major risk factor for perinatal and maternal morbidity and mortality in developing countries such as Senegal. With this in mind, the objectives of our study were to describe the epidemiological, clinical, paraclinical and evolutionary characteristics of macrosomic newborns admitted to the Pikine National Hospital Center and to study the factors associated with macrosomia. Materials and methods: This was a prospective study conducted over a period of 6 months, from 1 December 2021 to 30 June 2022 at the CHN of Pikine. Results: The hospital prevalence was 4.79%. The most represented maternal age group was between 25 and 35 years. The medical-obstetric pathologies during pregnancy were dominated by gestational diabetes (46.1%). The average maternal body mass index (BMI) during pregnancy was 28.47 ± 4.7 kg/m². The majority of macrosomic babies were born at term. Macrosomia was Grade 1 in 75.65% of cases. The main complications were hypoglycaemia and obstetric trauma. Cardiac abnormalities were found in newborns of diabetic mothers. Mortality was 2.61%. Factors that were significantly associated with macrosomia were: multiple gestations, multiple pregnancies and a history of macrosomia. Conclusion and recommendations: Even if its incidence seems low compared to LBW, fetal macrosomia can lead to obstetrical and neonatal complications that can be dramatic for the mother and/or the newborn; hence the need to ensure their prevention through better monitoring of pregnancy and delivery in all pregnant women at risk.

show abstract

Section: Maternal Medical and Gynaeco-obstetric Datasupporting

confidence: 90%

Fetal Macrosomia And Associated Factors at The National Hospital Center of Pikine (CHNP) Dakar/ Senegal

Ly¹,

Fall²,

Kane³

et al. 2022

Pediatr Neonatol Med

View full text Add to dashboard Cite

show abstract

“…In this study, 8,268 deliveries were performed between January 2007 to December 2016. Out of the 8,268 deliveries, 308 cases were diagnosed with macrosomia with a frequency of 3.7% [13]. Two case-control studies were performed in Romania.…”

Section: Discussionmentioning

confidence: 99%

Fetal Macrosomia Among Non-diabetic Women: Our Experience in a Developing Country

Shafqat¹,

Zeb²,

Yasmin³

2022

Cureus

View full text Add to dashboard Cite

BackgroundThe prevalence of fetal macrosomia varies worldwide. Its trend has increased over the past decades in many developed nations. It is associated with various maternal and fetal complications. The information regarding the frequency of fetal macrosomia among non-diabetic women is limited in resource-limited countries such as Pakistan. Therefore, this study aimed to determine the number of fetal macrosomia cases among nondiabetic women. MethodologyThis was a cross-sectional study conducted in a tertiary care hospital in Peshawar, Pakistan. A total of 119 pregnant women were enrolled in the study. All pregnant women aged 15 to 45 years who had singleton pregnancies with any parity or gravida and a gestational age of ≥37 weeks were included in the study. Pregnant women with underlying chronic systemic disorders such as diabetes mellitus, gestational diabetes mellitus, hypertension, renal or cardiac disorders, and sickle cell anemia were excluded from the study. Women who did not consent to participate and those with a gestational age of ≥42 weeks at the time of delivery were also excluded from our study. Based on a 5.2% prevalence of fetal macrosomia in the general population, the sample size was calculated using the World Health Organization calculator at a confidence interval of 95%, absolute precision of 0.05 with anticipated population proportion, and a 4% margin of error. The required sample size was calculated at 119. The chi-square test was applied. P-values of ≤0.05 were considered significant. ResultsOut of 119 participants, fetal macrosomia among non-diabetic women was seen in 10 (8.4%) cases. The mean age of patients in our study was 29.80 ± 4.33 years. The mean gestational age was 36.05 ± 1.31 weeks, whereas the mean body mass index of participants was 29.17 ± 2.36 kg/m 2 . Post-stratification, spontaneous vaginal delivery was the only significant variable with a P-value of <0.05 in our study. ConclusionsThe number of fetal macrosomia among non-diabetic women in our study was 10 (8.4%). Because this was a single-center, hospital-based, cross-sectional study, we need to conduct large multi-centered randomized controlled studies to identify the actual prevalence of fetal macrosomia in non-diabetic women in our population.

show abstract

Makrozomik Fetuslarda Doğum Şekli Oluşabilecek Komplikasyonları Önler mi?

Aksakal

Özdemirci

Bocutoğlu³

et al. 2018

Zeynep Kamil Tıp Bülteni

View full text Add to dashboard Cite

Amaç: Bu çalışmada, 4000 gr ve üzerinde bebek doğuran 643 gebenin doğum şeklinin ve doğum ağırlıklarının maternal ve neonatal komplikasyonlar üzerine olan etkisinin değerlendirilmesi amaçlanmıştır. Materyal metod: 643 hasta doğum şekline (vajinal veya sezaryen) ve doğum ağırlıklarına (4000-4500 ve ≥4500 gram) göre gruplara ayrıldı. 4000 gramın üzerinde doğum yapan hastalar doğum şekline göre komplikasyon oranları açısından karşılaştırıldı. Daha sonra hastalar 4000-4499 gr ve ≥4500 gr doğum yapanlar olarak ayrıldı. Bu iki grubun kendi içinde komplikasyon açısından fark olup olmadığı araştırıldı. Bulgular: Makrozomik infant öyküsü, neonatal ağırlık ve eşlik eden DM, sezaryen ile doğum yapan grupta yüksek saptandı. Neonatal komplikasyonlar açısından herhangi bir fark saptanmadı. maternal postpartum Hb değeri sezaryen olan grupta anlamlı düşük bulundu. 4500 gramın üzerinde doğan bebeklerin doğum şekli ile komplikasyon oranları değişmezken, 4000-4499 gram arasında postpartum Hb değeri sezaryen olan grupta anlamlı düşük saptandı. Sonuç: Rutin sezaryen ile doğumun makrozomik infantlarda komplikasyonları azaltma açısından belirgin bir üstünlük sağlamadığı görülmektedir. Makrozomik infant doğurma riski olan hastalar kişiselleştirilmeli ve doğum komplikasyonu açısından risk taşıyan hastalar sezaryene yönlendirilmelidir.

show abstract

Trends of Macrosomia at University Clinics of Kinshasa

Cited by 3 publications

References 22 publications

Fetal Macrosomia And Associated Factors at The National Hospital Center of Pikine (CHNP) Dakar/ Senegal

Fetal Macrosomia And Associated Factors at The National Hospital Center of Pikine (CHNP) Dakar/ Senegal

Fetal Macrosomia Among Non-diabetic Women: Our Experience in a Developing Country

Makrozomik Fetuslarda Doğum Şekli Oluşabilecek Komplikasyonları Önler mi?

Contact Info

Product

Resources

About